Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylinositol 4,5-bisphosphate 3‑kinase delta is a class IA lipid kinase crucial for generating second messengers that regulate survival/proliferation signals predominantly within leukocytes. Its precise regulation underpins normal immunity while dysregulation causes immunodeficiencies like APDS or contributes to cancer pathogenesis. Selective pharmacological inhibition offers targeted therapy options but requires careful balancing between efficacy and safety.
Inhibition of PI3Kδ catalytic activity, preventing the conversion of PtdIns(4,5)P₂ to PtdIns(3,4,5)P₃ and subsequent activation of downstream signaling pathways like AKT/mTOR.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol 4,5-bisphosphate 3-kinase delta (PI3Kδ).